Anti‐TNF‐induced lupus in patients with inflammatory bowel disease

BACKGROUND AND AIMS: Anti‐Tumor Necrosis Factor (TNF)‐induced lupus (ATIL) is a distinct clinical entity, increasingly recognized in patients with inflammatory bowel disease treated with anti‐TNF therapy. Our aims were to evaluate the incidence and clinical and serological markers of ATIL in this po...

Descripción completa

Detalles Bibliográficos
Autores principales: Picardo, Sherman, So, Kenji, Venugopal, Kannan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273700/
https://www.ncbi.nlm.nih.gov/pubmed/32514462
http://dx.doi.org/10.1002/jgh3.12291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273700/
https://www.ncbi.nlm.nih.gov/pubmed/32514462
http://dx.doi.org/10.1002/jgh3.12291

Ejemplares similares